Factsheet
January 30, 2019

Assay Development for Large-Scale Clinical Studies

Bioanalytical expertise to support large-scale, international studies
Taking a candidate drug to market – and to the patients who will benefit from it – requires supporting data from high-volume, regulated clinical studies. From sample receipt to final reporting, Q2 Solutions understands the importance of delivering qualified clinical sample data throughout all stages of the drug development cycle. Our bioanalytical experts can partner with you to develop assays that incorporate state-of-the-art instrumentation, rigorous quality control, and a logistics infrastructure to support large-scale, international studies.

Download our factsheet to learn more about our ability to support large-scale clinical projects.

Related Services:
Bioanalytical & ADME Laboratory Services

Accelerate and enhance your discovery, preclinical and clinical programs

Validated bioanalytical methods list

LC/MS/MS Methods, Immunoassay Biomarker Methods and LC/MS Biomarker Methods

High-Throughput ADME Screening Services

Capabilities that accelerate preclinical studies

Bioanalytical Immunoassay Services to Accelerate Biosimilar Development

Providing the tools and experience to support biosimilar studies

Read More